Sanginita Chemicals Limited — Others, 11-01-2025: Statement of deviation(s) or variation(s) under Reg. 32

Sanginita Chemicals Ltd. has disclosed a deviation analysis regarding its rights issue, where ₹15.54 crore was successfully raised. The report confirms that all funds have been fully utilized as planned, with no deviations in their intended purposes. Minor adjustments were made in capital expenditures and general corporate purposes, but the overall allocation remains in line with the original objectives. The company's alignment with its fund usage reinforces operational stability and financial transparency. This could foster a positive outlook among investors, given the effective management of the raised capital.